康弘药业
(002773)
| 流通市值：134.28亿 | | | 总市值：180.12亿 |
| 流通股本：6.87亿 | | | 总股本：9.21亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,179,163,287 | 1,046,478,561.32 | 4,585,133,789.58 | 3,623,865,721.06 |
| 营业总成本 | 1,522,675,525.42 | 690,570,560.84 | 3,278,743,141.86 | 2,438,543,787.09 |
| 其他经营收益 | | | | |
| 营业利润 | 675,284,937.97 | 359,268,864.95 | 1,377,365,453.56 | 1,228,093,544.11 |
| 利润总额 | 660,387,336.78 | 358,511,883.12 | 1,356,113,549.83 | 1,208,450,737.95 |
| 净利润 | 554,945,878.85 | 303,203,363.73 | 1,145,503,613.71 | 1,021,124,394.93 |
| 每股收益 | | | | |
| 其他综合收益 | -1,693,472.61 | 273,714.13 | -126,281.75 | -322,319.27 |
| 综合收益总额 | 553,252,406.24 | 303,477,077.86 | 1,145,377,331.96 | 1,020,802,075.66 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 7,153,875,353.9 | 7,439,323,596.84 | 7,084,460,574.88 | 7,023,154,380.28 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,785,221,052.15 | 2,770,197,721.23 | 2,835,404,169.79 | 2,846,879,479.34 |
| 资产总计 | 9,939,096,406.05 | 10,209,521,318.07 | 9,919,864,744.67 | 9,870,033,859.62 |
| 流动负债: | | | | |
| 流动负债合计 | 712,987,408.17 | 585,929,930.42 | 601,716,725.88 | 678,189,594.14 |
| 非流动负债: | | | | |
| 非流动负债合计 | 45,315,121.22 | 45,466,403.94 | 43,500,112.94 | 41,790,466.33 |
| 负债合计 | 758,302,529.39 | 631,396,334.36 | 645,216,838.82 | 719,980,060.47 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 9,214,862,815.85 | 9,606,672,334.71 | 9,298,916,486.14 | 9,166,361,019 |
| 股东权益合计 | 9,180,793,876.66 | 9,578,124,983.71 | 9,274,647,905.85 | 9,150,053,799.15 |
| 负债和股东权益合计 | 9,939,096,406.05 | 10,209,521,318.07 | 9,919,864,744.67 | 9,870,033,859.62 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,303,548,297.62 | 1,192,884,200.57 | 5,096,077,203.77 | 3,986,339,017.66 |
| 经营活动现金流出小计 | 1,763,776,557.25 | 848,573,489.19 | 3,592,428,751.05 | 2,578,063,329.64 |
| 经营活动产生的现金流量净额 | 539,771,740.37 | 344,310,711.38 | 1,503,648,452.72 | 1,408,275,688.02 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,243,361,727.05 | 27,567.61 | 5,993,368,067.74 | 3,252,470,799.99 |
| 投资活动现金流出小计 | 4,304,692,447.67 | 509,754,905.95 | 6,218,734,608.58 | 5,985,103,898.11 |
| 投资活动产生的现金流量净额 | -3,061,330,720.62 | -509,727,338.34 | -225,366,540.84 | -2,732,633,098.12 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 74,736 | - | 35,067,485 | 35,047,485 |
| 筹资活动现金流出小计 | 500,938,376.38 | 1,267,868.41 | 554,590,178.97 | 554,159,752.76 |
| 筹资活动产生的现金流量净额 | -500,863,640.38 | -1,267,868.41 | -519,522,693.97 | -519,112,267.76 |
| 汇率变动对现金及现金等价物的影响 | -247,626.47 | -157,509.87 | -482,965.57 | -551,595.52 |
| 现金及现金等价物净增加额 | -3,022,670,247.1 | -166,842,005.24 | 758,276,252.34 | -1,844,021,273.38 |
| 期末现金及现金等价物余额 | 3,361,033,251.8 | 6,216,861,493.66 | 6,383,703,498.9 | 3,781,405,973.18 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -3,022,670,247.1 | - | 758,276,252.34 | - |
最新报告期：2026-08-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西南证券 | 杜向阳 | 1.08 | 1.24 | 1.49 | 2026-08-28 |
| 中泰证券 | 祝嘉琦,穆奕杉 | 1.08 | 1.26 | 1.43 | 2026-07-30 |